<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Clinical Educator | The Miller Lab</title>
    <link>/tags/clinical-educator/</link>
      <atom:link href="/tags/clinical-educator/index.xml" rel="self" type="application/rss+xml" />
    <description>Clinical Educator</description>
    <generator>Source Themes Academic (https://sourcethemes.com/academic/)</generator><language>en-us</language><lastBuildDate>Sun, 08 Dec 2019 00:00:00 +0000</lastBuildDate>
    <image>
      <url>/img/MLab_logo_5.png</url>
      <title>Clinical Educator</title>
      <link>/tags/clinical-educator/</link>
    </image>
    
    <item>
      <title>Melanoma - Pathogenesis, Diagnosis and Work Up</title>
      <link>/slides/melanoma_12_13_19-primer/</link>
      <pubDate>Sun, 08 Dec 2019 00:00:00 +0000</pubDate>
      <guid>/slides/melanoma_12_13_19-primer/</guid>
      <description>


&lt;section data-noprocess data-shortcode-slide
  
      
      data-background-image=&#34;./Slides/Intro-Slide.jpg&#34;
  &gt;


&lt;hr /&gt;

&lt;h2 id=&#34;learning-objectives&#34;&gt;Learning Objectives&lt;/h2&gt;

&lt;ul&gt;
&lt;li&gt;Review basic epidemiology of melanoma&lt;/li&gt;
&lt;li&gt;Review molecular mechanisms of melanoma&lt;/li&gt;
&lt;li&gt;Discuss risk factors for melanoma&lt;/li&gt;
&lt;li&gt;Review how to evaluate and stage patients&lt;/li&gt;
&lt;li&gt;Overview of management of melanoma&lt;/li&gt;
&lt;/ul&gt;

&lt;hr /&gt;

&lt;h2 id=&#34;epidemiology&#34;&gt;Epidemiology&lt;/h2&gt;

&lt;ul&gt;
&lt;li&gt;1:25 Americans will get some kind of melanoma in their lifetime&lt;/li&gt;
&lt;li&gt;1:52 Americans will get an invasive melanoma in their lifetime&lt;/li&gt;
&lt;li&gt;Estimated to be 96,480 newly diagnosed cases of invasive melanoma in the U.S. in 2019

&lt;ul&gt;
&lt;li&gt;95,830 cases of melanoma in situ&lt;/li&gt;
&lt;/ul&gt;&lt;/li&gt;
&lt;li&gt;Between 9,000-10,000 deaths annually&lt;/li&gt;
&lt;/ul&gt;

&lt;hr /&gt;

&lt;h2 id=&#34;melanoma-pathogenesis&#34;&gt;Melanoma Pathogenesis&lt;/h2&gt;

&lt;hr /&gt;


&lt;section data-noprocess data-shortcode-slide
  
      
      data-background-image=&#34;./Slides/melanoma-pathways.jpg&#34;
  &gt;


&lt;hr /&gt;


&lt;section data-noprocess data-shortcode-slide
  
      
      data-background-image=&#34;./Slides/melanoma-pathways-legend.jpg&#34;
  &gt;


&lt;hr /&gt;


&lt;section data-noprocess data-shortcode-slide
  
      
      data-background-image=&#34;./Slides/cell-cycle.jpg&#34;
  &gt;


&lt;hr /&gt;


&lt;section data-noprocess data-shortcode-slide
  
      
      data-background-image=&#34;./Slides/legend-cell-cycle.jpg&#34;
  &gt;


&lt;hr /&gt;


&lt;section data-noprocess data-shortcode-slide
  
      
      data-background-image=&#34;./Slides/senescence.jpg&#34;
  &gt;


&lt;hr /&gt;


&lt;section data-noprocess data-shortcode-slide
  
      
      data-background-image=&#34;./Slides/legend-senescence.jpg&#34;
  &gt;


&lt;hr /&gt;

&lt;h3 id=&#34;susceptibility-to-cutaneous-malignant-melanoma-cmm&#34;&gt;Susceptibility to Cutaneous Malignant Melanoma (CMM)&lt;/h3&gt;

&lt;ul&gt;
&lt;li&gt;CMM1 has been mapped to chromosome 1p36.&lt;/li&gt;
&lt;li&gt;CMM2 – CDKN2A (9p21)&lt;/li&gt;
&lt;li&gt;CMM3 – CDK4 (12q14)&lt;/li&gt;
&lt;li&gt;CMM4 – mapped to chromosome 1p22&lt;/li&gt;
&lt;li&gt;CMM5 – MC1R (16q24)&lt;/li&gt;
&lt;li&gt;CMM6 – XRCC3 (14q32)&lt;/li&gt;
&lt;li&gt;CMM7 – mapped to chromosome 20q11&lt;/li&gt;
&lt;li&gt;CMM8 – MITF (3p13)&lt;/li&gt;
&lt;li&gt;CMM9 – TERT (5p15)&lt;/li&gt;
&lt;li&gt;CMM10 – POT1 (7q31)&lt;/li&gt;
&lt;/ul&gt;

&lt;hr /&gt;


&lt;section data-noprocess data-shortcode-slide
  
      
      data-background-image=&#34;./Slides/CDKN2A.jpg&#34;
  &gt;


&lt;hr /&gt;


&lt;section data-noprocess data-shortcode-slide
  
      
      data-background-image=&#34;./Slides/Prognosis.jpg&#34;
  &gt;


&lt;hr /&gt;


&lt;section data-noprocess data-shortcode-slide
  
      
      data-background-image=&#34;./Slides/Tx-strategies.jpg&#34;
  &gt;


&lt;hr /&gt;


&lt;section data-noprocess data-shortcode-slide
  
      
      data-background-image=&#34;./Slides/Approved-Tx.jpg&#34;
  &gt;


&lt;hr /&gt;


&lt;section data-noprocess data-shortcode-slide
  
      
      data-background-image=&#34;./Slides/CIT.jpg&#34;
  &gt;


&lt;hr /&gt;


&lt;section data-noprocess data-shortcode-slide
  
      
      data-background-image=&#34;./Slides/Legend-CIT.jpg&#34;
  &gt;


&lt;hr /&gt;


&lt;section data-noprocess data-shortcode-slide
  
      
      data-background-image=&#34;./Slides/Stage-3-Tx.jpg&#34;
  &gt;


&lt;hr /&gt;


&lt;section data-noprocess data-shortcode-slide
  
      
      data-background-image=&#34;./Slides/Tx-Metastatic-Dz.jpg&#34;
  &gt;


&lt;hr /&gt;
</description>
    </item>
    
  </channel>
</rss>
